129 related articles for article (PubMed ID: 31585264)
1. Chiral resolution of a caged xanthone and evaluation across a broad spectrum of breast cancer subtypes.
Chantarasriwong O; Dorwart TJ; Morales TH; Maggio SF; Settle AL; Milcarek AT; Alpaugh ML; Theodoraki MA; Theodorakis EA
Bioorg Chem; 2019 Dec; 93():103303. PubMed ID: 31585264
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pharmacophoric motif of the caged Garcinia xanthones.
Chantarasriwong O; Cho WC; Batova A; Chavasiri W; Moore C; Rheingold AL; Theodorakis EA
Org Biomol Chem; 2009 Dec; 7(23):4886-94. PubMed ID: 19907779
[TBL] [Abstract][Full Text] [Related]
3. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer.
Chantarasriwong O; Milcarek AT; Morales TH; Settle AL; Rezende CO; Althufairi BD; Theodoraki MA; Alpaugh ML; Theodorakis EA
Eur J Med Chem; 2019 Apr; 168():405-413. PubMed ID: 30831408
[TBL] [Abstract][Full Text] [Related]
5. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244
[TBL] [Abstract][Full Text] [Related]
6. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
Li X; Wu Y; Wang Y; You Q; Zhang X
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
[No Abstract] [Full Text] [Related]
7. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.
Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM
Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197
[TBL] [Abstract][Full Text] [Related]
8. Three types of cytotoxic natural caged-scaffolds: pure enantiomers or partial racemates.
Boonnak N; Chantrapromma S; Fun HK; Yuenyongsawad S; Patrick BO; Maneerat W; Williams DE; Andersen RJ
J Nat Prod; 2014 Jul; 77(7):1562-71. PubMed ID: 24940955
[TBL] [Abstract][Full Text] [Related]
9. Caged Garcinia xanthones: development since 1937.
Han QB; Xu HX
Curr Med Chem; 2009; 16(28):3775-96. PubMed ID: 19747141
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of caged Garcinia xanthones.
Batova A; Lam T; Wascholowski V; Yu AL; Giannis A; Theodorakis EA
Org Biomol Chem; 2007 Feb; 5(3):494-500. PubMed ID: 17252132
[TBL] [Abstract][Full Text] [Related]
12. Chiral derivatives of xanthones and benzophenones: Synthesis, enantioseparation, molecular docking, and tumor cell growth inhibition studies.
Phyo YZ; Teixeira J; Gonçalves R; Palmeira A; Tiritan ME; Bousbaa H; Pinto MMM; Fernandes C; Kijjoa A
Chirality; 2021 Apr; 33(4):153-166. PubMed ID: 33448056
[TBL] [Abstract][Full Text] [Related]
13. Bioactive scalemic caged xanthones from the leaves of Garcinia bracteata.
Zhang BJ; Fu WW; Wu R; Yang JL; Yao CY; Yan BX; Tan HS; Zheng CW; Song ZJ; Xu HX
Bioorg Chem; 2019 Feb; 82():274-283. PubMed ID: 30396061
[TBL] [Abstract][Full Text] [Related]
14. Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro.
Szkaradek N; Sypniewski D; Żelaszczyk D; Gałka S; Borzdziłowska P; Marona H; Bednarek I
Anticancer Agents Med Chem; 2019; 19(16):1949-1965. PubMed ID: 30950354
[TBL] [Abstract][Full Text] [Related]
15. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.
Zhang X; Li X; Ye S; Zhang Y; Tao L; Gao Y; Gong D; Xi M; Meng H; Zhang M; Gao W; Xu X; Guo Q; You Q
Med Chem; 2012 Nov; 8(6):1012-25. PubMed ID: 22779801
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional optimization of promising antitumor xanthone derivatives.
Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Wang HF; Yan H; Gao X; Niu B; Guo R; Wei L; Xu B; Tang N
Chem Pharm Bull (Tokyo); 2014; 62(3):260-6. PubMed ID: 24583780
[TBL] [Abstract][Full Text] [Related]
19. Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening.
Theodoraki MA; Rezende CO; Chantarasriwong O; Corben AD; Theodorakis EA; Alpaugh ML
Oncotarget; 2015 Aug; 6(25):21255-67. PubMed ID: 26101913
[TBL] [Abstract][Full Text] [Related]
20. Resolution and identification of scalemic caged xanthones from the leaf extract of Garcinia propinqua having potent cytotoxicities against colon cancer cells.
Sriyatep T; Tantapakul C; Andersen RJ; Patrick BO; Pyne SG; Muanprasat C; Seemakhan S; Borwornpinyo S; Laphookhieo S
Fitoterapia; 2018 Jan; 124():34-41. PubMed ID: 29031558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
